International Paper heads into its July 30 earnings report carrying a rare divergence: short sellers have been quietly building positions for weeks, even as Street analysts lifted price targets sharply just days ago.
The tension in the short interest data is the clearest place to start. Short interest has climbed to 10.4% of the free float — up 7.7% on the week and 22.6% over the past month, the highest level in the 30-day history of this data. That is a meaningful and accelerating build. The ORTEX short score has moved up alongside it, reaching 59.4 from around 57 a month ago, reflecting the gathering pressure. Yet despite the growing short position, the borrow market shows no stress: availability is running at nearly 800% — deep into the "plenty of supply" range — with cost to borrow holding below 0.5%. Bears are building, but they are doing so cheaply and without crowding each other out.
Options tell the same cautious story. The put/call ratio hit 1.75 on July 14, a 52-week high and the highest defensive reading on record in this dataset. It runs well above its 20-day average of 1.51, with a z-score nudging 1.3. The shift has been steady: just three weeks ago the PCR was sitting around 1.11 to 1.24. Since late June it has climbed in almost every session. Taken alongside the short-interest build, the options market suggests investors are actively hedging rather than simply ignoring downside risk. The closest peer, , fell 4.6% on the week — slightly more than IP's 3.7% decline — while and both dropped in the 2.5–2.9% range, suggesting the weakness is sector-wide rather than idiosyncratic.
The Street, however, has been moving the other way. In the last week alone, target prices have been lifted across four separate firms — Truist, Citi, JP Morgan, and Wells Fargo all raised targets between July 9 and July 15. JP Morgan's target went from $43 to $51, a 19% jump while keeping a Neutral rating. Truist moved to $46 from $40 on a maintained Buy. Citi added $7 to reach $43, also Buy. The consensus mean target is $41.90, roughly 15% above the current price of $36.50. Bulls cite the surprise earnings beat last quarter, expanding operating margins, and raised full-year guidance. Bears point to containerboard pricing headwinds and question whether the margin gains are durable. With a P/E around 19x and EV/EBITDA near 8x — and price-to-book at 1.4x, up meaningfully over the past month — valuation has re-rated higher even as the stock has dipped. The EPS momentum score ranks in the 80th percentile over 30 days, suggesting near-term estimate revisions have been running in the right direction.
On ownership, Capital Research & Management stands as the largest holder at nearly 22% of shares, and added more than 13 million shares through June 30. BlackRock added 3.4 million shares in the same period. The institutional picture is not one of distribution. Insider data is dated to May 12, but the most recent meaningful open-market activity was a director purchase of $313,000 in early May at $31.30 — below the current price and ahead of the post-earnings rally.
The key watch for July 30 is whether earnings repeat the Q1 pattern. The last print produced a 5.4% one-day decline, with further weakness in the five days following. The print before that was nearly flat on the day. Analysts have just reset targets higher; shorts and options traders have simultaneously loaded up on protection. The next release will therefore be less about whether the recovery thesis is intact and more about whether the magnitude of improvement is enough to justify a stock that has re-rated into those newly raised targets.
See the live data behind this article on ORTEX.
Open IP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
